114 results
Page 2 of 6
8-K
EX-99.1
ype279rtvk
11 May 22
Cocrystal Pharma Reports First Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs and Milestones
8:30am
8-K
EX-99.1
iajpvf 4g
23 Mar 22
Cocrystal Pharma Reports 2021 Financial Results and Provides Updates on Development Programs and Milestones
4:05pm
8-K
EX-99.1
g3210s
22 Dec 21
Regulation FD Disclosure
8:30am
8-K
EX-99.1
b487ckhe8ouangcr7d
15 Nov 21
Cocrystal Pharma Reports Third Quarter Financial Results and Provides an Update on Development
8:00am
8-K
EX-1.1
k6facoj5e5v7s s1z
5 May 21
Entry into a Material Definitive Agreement
5:02pm
8-K
EX-1.1
ws2 5ecdyv
27 Aug 20
Entry into a Material Definitive Agreement
5:25pm
424B5
jntzjrlu ht47qs9w11d
27 Aug 20
Prospectus supplement for primary offering
5:24pm
424B5
tzyvc ga0t9suxt8
26 Aug 20
Prospectus supplement for primary offering
5:30pm
8-K
EX-1.1
sr3r8my4xh361
2 Jul 20
Entry into a Material Definitive Agreement
9:30am
424B5
drwt7h
1 Jul 20
Prospectus supplement for primary offering
4:49pm